Home > Boards > US Listed > Medical - Drugs >

Akorn Inc. (AKRX)

AKRX RSS Feed
Add AKRX Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 1/16/2020 9:55:05 AM - Followers: 15 - Board type: Free - Posts Today: 0

http://www.akorn.com/

Corporate Profile

Akorn is a niche generic pharmaceutical company engaged in the development, manufacture and marketing of multi-source and branded pharmaceutical products in the areas of ophthalmology, antidotes, anti-infectives, and controlled substances for pain management and anesthesia in the United States and across the globe.

Our customers include physicians, optometrists, hospitals, surgery centers, clinics, long-term care, wholesalers, group purchasing organizations, retail pharmacies, and other pharmaceutical companies.

Akorn is committed to serving our customers by providing an extensive line of affordable, safe and efficacious pharmaceuticals the following markets:
 

  • Ophthalmologic Pharmaceuticals: Solutions, Ointments, Gels, and Injectables

    The Company’s Ophthalmic segment markets diagnostic products, including mydriatics and cycloplegics, anesthetics, topical stains, gonioscopic solutions, and angiography dyes, which are used in the office setting.

    We also sell therapeutic products, such as antibiotics, anti-infectives, steroids, steroid combinations, glaucoma medications, decongestants/antihistamines, and anti-edema medications to wholesalers, chain drug stores, and other national account customers. In addition, this segment offers non-pharmaceutical products, including various artificial tear solutions, and preservative-free lubricating ointments.

  • Specialty Therapeutics and Injectable Pharmaceuticals: Liquid and Lyophilized

    The Company's Specialty Therapeutics and Injectable segment markets hospital drug and injectable pharmaceutical products, including antidotes, anti-infectives, and controlled substances for pain management and anesthesia; and other pharmaceutical products. This segment markets products to hospitals through the wholesale distribution channel. 

     
  • Contract Manufacturing
    Our Contract Service segment manufactures aseptic filled and terminally sterilized ophthalmic and injectable pharmaceutical products from our facilities in Somerset, NJ and Decatur, IL for third party pharmaceutical customers.

Akorn was founded in 1971 and is headquartered in Lake Forest, Illinois.


 

Know The Leadership

         

Know The Directors

http://www.akorn.com/management_team.php   http://www.akorn.com/board_of_directors.php

Know the Products A-Z

         

Keep Updated With The Company News

http://www.akorn.com/catalog_all.php   http://www.akorn.com/news_releases.php

Daily

         

Weekly

 

 Longer Term Weekly

Point & Figure Chart


INSIDER TRANSACTIONS REPORTED - LAST TWO YEARS

Short Interest

http://pinksheets.com/pink/quote/quote.jsp?symbol=akrx

 


"We expect to add other vaccines produced by third party biologics manufacturers in the future..."

(an excerpt from recent filing).


 


FDA approval website

http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Reports.MonthlyApprovalsAll

 

AKRX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AKRX News: Akorn Announces Extension of Standstill Agreement 12/16/2019 07:51:52 AM
AKRX News: Current Report Filing (8-k) 11/12/2019 04:02:08 PM
AKRX News: Current Report Filing (8-k) 11/12/2019 02:01:59 PM
AKRX News: Current Report Filing (8-k) 11/06/2019 06:04:42 AM
AKRX News: Akorn to Present at the Credit Suisse Healthcare Conference 11/05/2019 07:00:00 PM
PostSubject
#875   Up 1,46. Juho 01/16/20 09:55:05 AM
#874   * * $AKRX Video Chart 01-13-2020 * * ClayTrader 01/13/20 06:05:02 PM
#873   Good news AH?? Juho 01/13/20 01:20:03 PM
#872   It's up. 1,40 dollar. Juho 01/13/20 11:44:49 AM
#871   Run away would be my best advice. BioChica 01/10/20 02:56:18 PM
#870   Adding 1.25 just about bottom.?. DailyX 01/09/20 06:00:45 PM
#869   * * $AKRX Video Chart 12-18-2019 * * ClayTrader 12/18/19 05:41:25 PM
#868   under 2 was a gift.. this had to Tduggylolz 12/18/19 02:27:43 PM
#867   CHOO CHOOOO Tduggylolz 12/18/19 02:25:49 PM
#866   Watching here for an entry. RJ Trotts 12/18/19 01:40:05 PM
#865   Added some at 2.11, let see if DailyX 12/18/19 12:00:50 PM
#864   full blown selloff... sucks Tduggylolz 12/18/19 10:07:47 AM
#863   full blown selloff... sucks Tduggylolz 12/18/19 10:07:43 AM
#862   * * $AKRX Video Chart 10-17-2019 * * ClayTrader 10/17/19 05:30:50 PM
#861   * * $AKRX Video Chart 09-20-2019 * * ClayTrader 09/20/19 05:46:43 PM
#860   * * $AKRX Video Chart 08-28-2019 * * ClayTrader 08/28/19 05:36:57 PM
#859   * * $AKRX Video Chart 08-26-2019 * * ClayTrader 08/26/19 05:52:45 PM
#858   News: $AKRX Akorn Receives FDA Approval for Azelastine whytestocks 08/26/19 02:10:27 PM
#857   News: $AKRX Akorn Announces Launch of Loteprednol Etabonate whytestocks 06/28/19 08:30:30 AM
#856   another inside buyer - director realfast95 06/04/19 04:48:25 PM
#855   inside buyer - director realfast95 05/30/19 09:53:14 AM
#854   * * $AKRX Video Chart 05-08-2019 * * ClayTrader 05/08/19 04:09:32 PM
#853   Akorn (NASDAQ:AKRX) had its price target upped by realfast95 05/08/19 08:44:29 AM
#852   * * $AKRX Video Chart 05-07-2019 * * ClayTrader 05/07/19 05:47:49 PM
#851   News: $AKRX Akorn Provides Preliminary First Quarter 2019 whytestocks 05/07/19 11:00:37 AM
#850   * * $AKRX Video Chart 04-22-2019 * * ClayTrader 04/22/19 05:28:20 PM
#849   News: $AKRX FINAL DEADLINE ALERT - AKRX, HIIQ whytestocks 04/22/19 03:10:45 PM
#848   News: $AKRX FINAL DEADLINE - AKRX, HIIQ & whytestocks 04/22/19 10:50:38 AM
#847   New management supposedly... Possibly can turn it around. mbel18 03/18/19 11:04:03 PM
#846   Company is toast, it's not going anywhere Paullee 03/18/19 10:57:29 PM
#845   Not much activity on this board mbel18 03/18/19 09:48:35 PM
#844   * * $AKRX Video Chart 12-07-18 * * ClayTrader 12/07/18 05:36:20 PM
#843   Looks like they will lose the take over micar 12/06/18 10:44:39 AM
#842   https://ih.advfn.com/p.php?pid=nmona&article=78660348&symbol=AKRX LexTrader 11/10/18 06:47:28 AM
#841   Time for a pop! sorkin 10/16/18 08:51:01 AM
#840   Akorn will tell them where to put their offer. LexTrader 10/01/18 02:25:22 PM
#839   Truth is Fresenius will go ahead with the sorkin 10/01/18 11:29:37 AM
#838   Judge says Fresenius can walk away from $4.8 Paullee 10/01/18 09:46:08 AM
#837   What’s up! sorkin 10/01/18 08:53:12 AM
#836   Just popped again LexTrader 07/05/18 03:02:18 PM
#835   Nice vol on the close! LexTrader 06/29/18 04:02:28 PM
#834   Any chance of a renegotiated offer? Maybe 24.00 LexTrader 06/19/18 03:13:07 PM
#833   Sure like the way this is acting. LexTrader 05/30/18 02:35:53 PM
#832   M&A SPECIAL SITUATIONS stockguard 05/13/18 02:35:36 PM
#831   https://seekingalpha.com/article/4171157-sa-interview-event-driven-investing-don stockguard 05/13/18 02:33:28 PM
#830   Bull bet on this under the radar pharma stock stockguard 05/11/18 05:35:14 PM
#829   MA 2 realfast95 05/09/18 08:27:13 PM
#828   AKRX files reply to Fresenius counterclaim - still realfast95 05/09/18 07:35:25 AM
#827   Fresenius' (FSNUY) CEO Stephan Sturm on Q1 2018 realfast95 05/09/18 07:33:31 AM
#826   RBC Captial analyst Randall Stanicky notes Akorn (NASDAQ: realfast95 05/09/18 07:26:16 AM
PostSubject